BioCentury
ARTICLE | Company News

Domain, Prexton in PD option deal

January 23, 2013 2:16 AM UTC

Domain Therapeutics S.A. (Illkirch-Graffenstaden, France) granted Prexton Therapeutics S.A. (Plan les Ouates, Switzerland) an exclusive option to license metabotropic glutamate receptor 4 ( mGluR4) po...